Peter Hnik Net Worth

Peter Hnik biography

Dr. Peter Hnik, M.D. is the Chief Medical Officer of iCo Therapeutics Inc. Dr. Hnik received his medical degree from the Medical Faculty of Charles University of Prague in 1981. After practicing for several years at university’s eye clinic, where he performed surgery and provided consultation services regarding glaucoma and neuro-ophthalmology, Dr. Hnik joined the eye clinic at the University of British Columbia, as part of the glaucoma research group. He received his Master of Health Sciences degree from the University of British Columbia in 1999. Prior to joining the Company, Dr. Hnik served as associate director of clinical research with QLT Inc., where he played a critical role in designing and directing clinical trials for treatment of age-related macular degeneration and diabetic retinopathy with Visudyne. He was also heavily involved in the publication, in-licensing and pharmacovigilance activities for Visudyne. Dr. Hnik is a member of the Association for Research in Vision and Ophthalmology, the American Academy of Ophthalmology, the New York Academy of Sciences, the European Society of Retina Specialists and the Drug Information Association.

What is the salary of Peter Hnik?

As the Chief Medical Officer of iCo Therapeutics, the total compensation of Peter Hnik at iCo Therapeutics is CAD$163,061. There are no executives at iCo Therapeutics getting paid more.